Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,044 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36).
Yokoyama H, Araki S, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group. Yokoyama H, et al. Among authors: oishi m. Diabetes Res Clin Pract. 2015 Sep;109(3):485-92. doi: 10.1016/j.diabres.2015.06.005. Epub 2015 Jul 16. Diabetes Res Clin Pract. 2015. PMID: 26261056
Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A; Japan Diabetes Clinical Data Management Study Group. Yokoyama H, et al. Among authors: oishi m. Diabetologia. 2012 Jul;55(7):1911-8. doi: 10.1007/s00125-012-2536-y. Epub 2012 Apr 4. Diabetologia. 2012. PMID: 22476921
Observational 6-month open-label study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen: 23rd article of the Japan Diabetes Clinical Data Management Study Group (JDDM23).
Oishi M, Abe N, Yokoyama H, Kuribayashi N, Tomonaga O, Matoba K, Kobayashi M; Japan Diabetes Clinical Data Management Study Group. Oishi M, et al. J Int Med Res. 2012;40(2):787-97. doi: 10.1177/147323001204000245. J Int Med Res. 2012. PMID: 22613444 Free article.
Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
Ito R, Yamakage H, Kotani K, Wada H, Otani S, Yonezawa K, Ogo A, Okajima T, Adachi M, Araki R, Yoshida K, Saito M, Nagaoka T, Toyonaga T, Tanaka T, Yamada T, Ota I, Oishi M, Miyanaga F, Shimatsu A, Satoh-Asahara N; Japan Diabetes and Obesity Study (J-DOS) Group. Ito R, et al. Among authors: oishi m. Endocr J. 2015;62(2):201-7. doi: 10.1507/endocrj.EJ14-0352. Epub 2014 Nov 14. Endocr J. 2015. PMID: 25399862 Free article.
Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS).
Satoh-Asahara N, Kotani K, Yamakage H, Yamada T, Araki R, Okajima T, Adachi M, Oishi M, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Satoh-Asahara N, et al. Among authors: oishi m. Atherosclerosis. 2015 Oct;242(2):461-8. doi: 10.1016/j.atherosclerosis.2015.08.003. Epub 2015 Aug 8. Atherosclerosis. 2015. PMID: 26295798
Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.
Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Oishi M, Himeno A, Kono S, Sugawara A, Hattori M, Ogawa Y, Shimatsu A; Japan Obesity and Metabolic Syndrome Study (JOMS) Group. Satoh-Asahara N, et al. Among authors: oishi m. Clin J Am Soc Nephrol. 2011 Feb;6(2):265-73. doi: 10.2215/CJN.04830610. Epub 2010 Nov 4. Clin J Am Soc Nephrol. 2011. PMID: 21051748 Free PMC article.
1,044 results